medical – Page 5 – cannabis.co.nz

February 3, 2023administration, analysis, analytics, business, Business Analysis, cannabis, cbd, compliance, Concentrates & Extracts, consumer, cultivation, Cultivation & Growing, dea, Dispensaries & Retail, dispensary, drug, Edibles & Processing, extraction, farm bill, FDA, Federal, food, framework, government, growing, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, pathway, product, products, Quality, recreational, regulation, regulations, regulatory, safety, state, test, USDA

FDA Punts on CBD Rules

On December 20, 2018, Former President Trump signed the Farm Bill into law, which removed hemp-derived cannabidiol (CBD) from the Controlled Substances […]

January 24, 2023analysis, analytics, banking, business, Business Analysis, cannabis, cash, cbd, claim, commercial, compensation, compliance, consumer, cover, coverage, CRB, crop, dispensaries, Dispensaries & Retail, dispensary, Federal, general, government, growing, industry, inland, insurance, insure, law, legal, legalization, legalize, legislation, liabilities, liability, license, management, marijuana, marine, market, medical, medicine, Operations, party, product, property, Quality, recreational, regulation, regulations, regulatory, retail, retailer, risk, safe, safety, shop, state, thc, third, worker

A Guide to Dispensary Insurance

As a business owner, insurance is always a must. If you are interested in entering into the cannabis industry or you already […]

January 11, 2023adult, analysis, analytics, business, Business Analysis, cannabis, clean slate, compliance, Connecticut, consumer, conviction, CQC, CQCExpo, CT, Dispensaries & Retail, dispensary, erase, expunge, fine fettle, government, Governor, growing, industry, launch, law, legal, legalization, legalize, legislation, legislature, license, lieutenant governor, marijuana, market, medical, medicine, Ned Lamont, Northeast, operate, product, recreational, regulation, regulations, regulatory, retail, sales, Susan Bysiewicz, test, use, Zenleaf

Connecticut Launches Adult Use Sales

The Connecticut Department of Consumer Protection approved nine licenses for dispensaries to commence adult use sales on Tuesday, January 10. While nine […]

January 11, 20232022, 2023, Act, agencies, analysis, analytics, banking, Biden, Brownstein, Brownstein Hyatt Farber Schreck, business, Business Analysis, california, cannabis, Cannabis Opportunity Act, CAOA, cbd, challenge, CLIMB, compliance, consumer, controlled substances act, CSA, cultivation, department of justice, dispensary, DOJ, extraction, Federal, government, growing, Harnessing Opportunities by Pursuing Expungement, HOPE, industry, Joe, law, legal, legalization, legalize, legislation, license, LLP, marijuana, Marijuana Opportunity Reinvestment and Expungement, market, medical, medicine, MORE, New, pardon, president, product, Quality, recreational, regulation, regulations, regulatory, safe, safety, state, thc, the States Reform Act, year

Cannabis in 2023: Here to Stay, but Major Challenges Remain

2022 brought more change and visibility to the cannabis industry than nearly any year before. Two of five legalization ballot measures passed, […]

January 10, 2023aeroponics, AEssenseGrows, analysis, analytics, business, Business Analysis, CanCann, cannabis, compliance, consumer, control, cultivation, Cultivation & Growing, Denmark, document, documentation, documented, employee, extraction, facilities, facility, FarmaGrowers, Federal, GMP, GMPs, good, government, grower, growing, Health Canada, industry, international, lab, law, legal, legalization, legalize, legislation, license, manufacturing, marijuana, market, medical, medicine, operating, Operations, personnel, Phil Gibson, practice, precision, procedure, procedures, process, product, Quality, recreational, regulation, regulations, regulatory, safety, sop, SOPs, South Africa., standard, Sustainability, test, Testing, thc, train, training

The 3-Legged Stool of Successful Grow Operations: Climate, Cultivation & Genetics – Part 6

This is Part 6 and the final chapter in The 3-Legged Stool of Successful Grow Operations series. Click here to see Part 1, here to see […]

January 5, 2023analysis, analytics, Bloomwell, business, Business Analysis, C-suite, CANADA, canadian, cannabis, capital, capitalist, cbd, compliance, consumer, cultivation, dispensary, EU, europe, European, export, extraction, Federal, finance, financing, German, Germany, government, growing, import, income, industry, international, invest, investing, investment, law, leadership, legal, legalization, legalize, legislation, leverage, license, Luxembourg, Malta, marijuana, market, medical, opportunities, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, Soapbox, state, statement, Tilray, VC, venture

Investment Strategies for Entering the European Cannabis Market

For U.S. venture capitalists (VCs), the burgeoning European cannabis market provides opportunities to break into the industry on the heels of adult-use […]

January 5, 2023adult, analysis, analytics, business, Business Analysis, cannabis, Chris Alexander, compliance, consumer, CQC, CQCExpo, Dispensaries & Retail, dispensary, government, growing, Housing Works Cannabis Co, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, new jersey, new york, New York Office of Cannabis Management, NY, NYOCM, OCM, product, Quality, recreational, regulation, regulations, regulatory, retail, safety, sales, state, test, use

New York Launches Adult Use Sales

On December 29 just before the end of 2022, New York officially launched legal adult use sales in the state, but at […]

December 22, 2022analysis, analytics, business, Business Analysis, cannabis, CANNAFlix, compliance, Conference, consumer, event, government, growing, industry, lab, laboratories, Laboratories & Analytics, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, Pesticide, product, Product Development, Quality, RC - Cannabis & Hemp Testing Solutions, RC - Cannabis Analysis, RC - Cannabis Testing Accreditation Center, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, virtual, webinar

2022 Cannabis Labs Virtual Conference: December Program

2022 Cannabis Labs Virtual Conference: December Program Sponsored by Avivatech & Millipore Sigma Click here to watch the recording Agenda Potency Inflation: […]

December 15, 2022analysis, analytics, Andreas, app, brand, business, Business Analysis, CA, california, cannabis, compliance, consumer, creative, creativity, cultivation, customer, data, develop, development, director, Dispensaries & Retail, dispensary, Dre, experience, extraction, Federal, government, growing, holdings, illinois, industry, Jushi, law, legal, legalization, legalize, license, marijuana, market, marketing, massachusetts, medical, medicine, MSO, Neumann, nevada, Ohio, Operations, Palm Springs, pennsylvania, platform, presence, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, SKU, state, Sustainability, thc, value, Virginia

Catching up with Jushi Creativity: A Q&A with Dre Neumann

Jushi Holdings is a large multi-state operator with a massive national footprint and a presence in key markets, including Pennsylvania, Illinois, Virginia, […]

December 10, 2022Affinity, analysis, analytics, bio, business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, growing, head, industry, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, medical, medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, Quality, regulation, regulatory, safety, state, studies, Study, test, Testing, therapeutics, to, trial, Zelira

First Pharma vs Cannabis Clinical Trial Moves Forward

Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in […]